Product Images Lyrica

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Lyrica NDC 58151-240 by Viatris Specialty Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Cockcroft and Gault Equation - image 01

Cockcroft and Gault Equation - image 01

Pregabalin Structural Formula - image 02

Pregabalin Structural Formula - image 02

Figure 1: Patients Achieving Various Levels of Improvement in Pain Intensity – Study DPN 1 - image 03

Figure 1: Patients Achieving Various Levels of Improvement in Pain Intensity – Study DPN 1 - image 03

Figure 2: Patients Achieving Various Levels of Improvement in Pain Intensity– Study DPN 2 - image 04

Figure 2: Patients Achieving Various Levels of Improvement in Pain Intensity– Study DPN 2 - image 04

This text appears to be a medication dosage instruction along with a measurement related to pain improvement. It is recommended to take 100 mg of Frogabain per day. Additionally, there seems to be a reference to the percentage of pain improvement from baseline.*

Figure 3: Patients Achieving Various Levels of Improvement in Pain Intensity– Study PHN 1 - image 05

Figure 3: Patients Achieving Various Levels of Improvement in Pain Intensity– Study PHN 1 - image 05

This text describes the percent of improvement in patients taking different doses of pregabalin multiple times a day compared to a placebo. It includes the improvement in pain from the baseline. The percentages of patients improved at various doses are listed in the text.*

Figure 4: Patients Achieving Various Levels of Improvement in Pain Intensity – Study PHN 2 - image 06

Figure 4: Patients Achieving Various Levels of Improvement in Pain Intensity – Study PHN 2 - image 06

This is a clinical trial data showing the percentage of patients' improvement in pain with different treatments: Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo. The text provides percentages of improvement in pain from baseline, indicating the efficacy of each treatment.*

Figure 5: Patients Achieving Various Levels of Improvement in Pain Intensity– Study PHN 3 - image 07

Figure 5: Patients Achieving Various Levels of Improvement in Pain Intensity– Study PHN 3 - image 07

Figure 6: Responder Rate by Adjunctive Epilepsy Study - image 08

Figure 6: Responder Rate by Adjunctive Epilepsy Study - image 08

Figure 7: Seizure Reduction by Dose (All Partial Onset Seizures) for Studies E1, E2, and E3 - image 09

Figure 7: Seizure Reduction by Dose (All Partial Onset Seizures) for Studies E1, E2, and E3 - image 09

Figure 8: Responder Rate (Greater than or Equal to 50% Reduction) - image 10

Figure 8: Responder Rate (Greater than or Equal to 50% Reduction) - image 10

Figure 9: Patients Achieving Various Levels of Improvement in Pain Intensity – Fibromyalgia Study F1 - image 11

Figure 9: Patients Achieving Various Levels of Improvement in Pain Intensity – Fibromyalgia Study F1 - image 11

This text mentions the percentage of patients improved after different daily doses of Pregabalin and Placebo. It also highlights the percentage improvement in pain from baseline.*

Figure 10: Time to Loss of Therapeutic Response, Fibromyalgia Study F2 (Kaplan-Meier Analysis) - image 12

Figure 10: Time to Loss of Therapeutic Response, Fibromyalgia Study F2 (Kaplan-Meier Analysis) - image 12

Figure 11: Patients Achieving Various Levels of Improvement in Pain Intensity – Study SCI 1 - image 13

Figure 11: Patients Achieving Various Levels of Improvement in Pain Intensity – Study SCI 1 - image 13

Figure 12: Patients Achieving Various Levels of Improvement in Pain Intensity – Study SCI 2 - image 14

Figure 12: Patients Achieving Various Levels of Improvement in Pain Intensity – Study SCI 2 - image 14

Lyrica Capsules 25 mg Bottle Label - image 15

Lyrica Capsules 25 mg Bottle Label - image 15

This text appears to be the package information for 90 capsules of Lyrica (pregabalin) containing 35mg of pregabalin in each capsule. The capsules should be stored at a temperature between 15-20°C (53-86°F). It emphasizes dispensing with a medication guide and advises referencing the prescribing information for dosage and usage instructions. This product is only available with a prescription.*

Lyrica Capsules 50 mg Bottle Label - image 16

Lyrica Capsules 50 mg Bottle Label - image 16

This text appears to be a prescription label for Lyrica (pregabalin) with instructions for storing at 25°C, the quantity of capsules (90), the drug name, and that it requires a prescription. It also mentions the need for a medication guide.*

Lyrica Capsules 75 mg Bottle Label - image 17

Lyrica Capsules 75 mg Bottle Label - image 17

This text appears to be a prescription label for a medication called Lyrica (pregabalin) in 75 mg capsules. It emphasizes the importance of dispensing with the medication guide and includes directions regarding dosage and use. The prescription is for 90 capsules and for prescription use only.*

Lyrica Capsules 100 mg Bottle Label - image 18

Lyrica Capsules 100 mg Bottle Label - image 18

This text provides important information about Lyrica capsules containing 100 mg of pregabalin. It advises to store at 25°C (77°F) and dispense in light-resistant containers. It is essential to dispense with the medication guide and contains 90 capsules for prescription use only.*

Lyrica Capsules 150 mg Bottle Label - image 19

Lyrica Capsules 150 mg Bottle Label - image 19

This text provides important information about storing pregabalin capsules, including the recommended temperature range and guidelines for dispensing in child-resistant containers. It also specifies the dosage strength of each capsule (150 mg) and the total quantity included in the packaging (90 capsules). Additionally, it emphasizes the necessity of providing a medication guide when dispensing Lyrica.*

Lyrica Capsules 200 mg Bottle Label - image 20

Lyrica Capsules 200 mg Bottle Label - image 20

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Dispense in tight, child-resistant containers. Each capsule contains 200 mg pregabalin. Always dispense with "MEDICATION GUIDE." 90 Capsules Rx only.*

Lyrica Capsules 225 mg Bottle Label - image 21

Lyrica Capsules 225 mg Bottle Label - image 21

This text provides information for storing Lyrica (pregabalin) capsules, recommending storage at 25°C with excursions between 15-30°C. It specifies dispensing in tight, child-resistant containers and mentions each capsule contains 225 mg of pregabalin. It advises to dispense with medication guide and states that 90 capsules are available by prescription only.*

Lyrica Capsules 300 mg Bottle Label - image 22

Lyrica Capsules 300 mg Bottle Label - image 22

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) (see USP Controlled Room Temperature). This medication contains 300 mg of pregabalin per capsule and comes in a pack of 90 capsules. Remember to dispense in tight (USP) capsules. Please refer to the accompanying prescribing information and always dispense with the Medication Guide. Make sure to keep the medication at the recommended temperature range.*

Lyrica Oral Solution 20 mg per mL Carton Label - image 23

Lyrica Oral Solution 20 mg per mL Carton Label - image 23

This text provides information about Lyrica (pregabalin) oral solution, with a concentration of 20 mg per mL in a 16 fl oz (473 mL) container. It gives storage instructions, dosage guidance, and indicates that it is available by prescription only. It is important to follow the recommended storage conditions and dosage instructions provided for this medication.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.